These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33067930)

  • 1. Social tariffs and democratic choice-Do population-based health state values reflect the will of the people?
    Schneider PP
    Health Econ; 2021 Jan; 30(1):104-112. PubMed ID: 33067930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and general public preferences for health states: A call to reconsider current guidelines.
    Versteegh MM; Brouwer WBF
    Soc Sci Med; 2016 Sep; 165():66-74. PubMed ID: 27497260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advocating a Paradigm Shift in Health-State Valuations: The Estimation of Time-Preference Corrected QALY Tariffs.
    Jonker MF; Donkers B; de Bekker-Grob EW; Stolk EA
    Value Health; 2018 Aug; 21(8):993-1001. PubMed ID: 30098678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-adjusted life-years. Ethical implications for physicians and policymakers.
    La Puma J; Lawlor EF
    JAMA; 1990 Jun; 263(21):2917-21. PubMed ID: 2110986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
    Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
    Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff.
    Comans TA; Nguyen KH; Ratcliffe J; Rowen D; Mulhern B
    Pharmacoeconomics; 2020 Aug; 38(8):871-881. PubMed ID: 32314315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the choice of tariff matter?: A comparison of EQ-5D-5L utility scores using Chinese, UK, and Japanese tariffs on patients with psoriasis vulgaris in Central South China.
    Zhao Y; Li SP; Liu L; Zhang JL; Chen G
    Medicine (Baltimore); 2017 Aug; 96(34):e7840. PubMed ID: 28834893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale-Eight Dimensions-Patient Version (MSIS-8D-P).
    Goodwin E; Green C; Hawton A
    Value Health; 2018 Nov; 21(11):1338-1345. PubMed ID: 30442282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The QALY is ableist: on the unethical implications of health states worse than dead.
    Schneider P
    Qual Life Res; 2022 May; 31(5):1545-1552. PubMed ID: 34882282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
    Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
    Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of health-Empirical issues when estimating the monetary value of a quality-adjusted life year based on well-being data.
    Himmler S; Stöckel J; van Exel J; Brouwer WBF
    Health Econ; 2021 Aug; 30(8):1849-1870. PubMed ID: 33951253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.
    Rankin J; Rowen D; Howe A; Cleland JGF; Whitty JA
    Heart Fail Rev; 2019 Jul; 24(4):549-563. PubMed ID: 30903357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of social care for adults: developing a preference-weighted measure.
    Netten A; Burge P; Malley J; Potoglou D; Towers AM; Brazier J; Flynn T; Forder J; Wall B
    Health Technol Assess; 2012; 16(16):1-166. PubMed ID: 22459668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating sign-dependence in health-related social welfare functions.
    Attema AE
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):223-8. PubMed ID: 25543906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A shortcut to mean-based time tradeoff tariffs for the EQ-5D?
    Rand-Hendriksen K; Augestad LA; Dahl FA; Kristiansen IS; Stavem K
    Med Decis Making; 2012; 32(4):569-77. PubMed ID: 22247424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
    Gabriel SE; Kneeland TS; Melton LJ; Moncur MM; Ettinger B; Tosteson AN
    Med Decis Making; 1999; 19(2):141-8. PubMed ID: 10231076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conceptual map of health-related quality of life dimensions: key lessons for a new instrument.
    Olsen JA; Misajon R
    Qual Life Res; 2020 Mar; 29(3):733-743. PubMed ID: 31676970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.